{
  "metformin_cancer": {
    "title": "Report Compilation Progress",
    "description": "Synthesizing insights from all analyses to produce a comprehensive repurposing report for Metformin.",
    "sections": [
      { "title": "Executive Summary", "status": "Complete", "color": "green" },
      { "title": "Market & Competitive Analysis", "status": "Complete", "color": "blue" },
      { "title": "Clinical & Mechanistic Rationale", "status": "Complete", "color": "green" },
      { "title": "Intellectual Property & FTO", "status": "In Progress", "color": "amber" },
      { "title": "Final Report Status", "status": "Finalizing", "color": "amber" }
    ],
    "report_file": "/reports/metformin_cancer_repurposing_report.pdf"
  },
  "sildenafil_altitude": {
    "title": "Report Compilation Progress",
    "description": "Synthesizing insights from all analyses to produce a comprehensive repurposing report for Sildenafil.",
    "sections": [
      { "title": "Executive Summary", "status": "Complete", "color": "green" },
      { "title": "Market & Competitive Analysis", "status": "Complete", "color": "blue" },
      { "title": "Clinical & Mechanistic Rationale", "status": "Complete", "color": "green" },
      { "title": "Intellectual Property & FTO", "status": "In Progress", "color": "amber" },
      { "title": "Final Report Status", "status": "Finalizing", "color": "amber" }
    ],
    "report_file": "/reports/sildenafil_altitude_repurposing_report.pdf"
  },
  "adalimumab_lungfibrosis": {
    "title": "Report Compilation Progress",
    "description": "Synthesizing insights from all analyses to produce a comprehensive repurposing report for Adalimumab.",
    "sections": [
      { "title": "Executive Summary", "status": "Complete", "color": "green" },
      { "title": "Market & Competitive Analysis", "status": "Complete", "color": "blue" },
      { "title": "Clinical & Mechanistic Rationale", "status": "Complete", "color": "green" },
      { "title": "Intellectual Property & FTO", "status": "In Progress", "color": "amber" },
      { "title": "Final Report Status", "status": "Finalizing", "color": "amber" }
    ],
    "report_file": "/reports/adalimumab_lungfibrosis_repurposing_report.pdf"
  },
  "fluoxetine_neurodegenerative": {
    "title": "Report Compilation Progress",
    "description": "Synthesizing insights from all analyses to produce a comprehensive repurposing report for Fluoxetine.",
    "sections": [
      { "title": "Executive Summary", "status": "Complete", "color": "green" },
      { "title": "Market & Competitive Analysis", "status": "Complete", "color": "blue" },
      { "title": "Clinical & Mechanistic Rationale", "status": "Complete", "color": "green" },
      { "title": "Intellectual Property & FTO", "status": "In Progress", "color": "amber" },
      { "title": "Final Report Status", "status": "Finalizing", "color": "amber" }
    ],
    "report_file": "/reports/fluoxetine_neurodegenerative_repurposing_report.pdf"
  },
  "pembrolizumab_NASH": {
    "title": "Report Compilation Progress",
    "description": "Synthesizing insights from all analyses to produce a comprehensive repurposing report for Pembrolizumab.",
    "sections": [
      { "title": "Executive Summary", "status": "Complete", "color": "green" },
      { "title": "Market & Competitive Analysis", "status": "Complete", "color": "blue" },
      { "title": "Clinical & Mechanistic Rationale", "status": "Complete", "color": "green" },
      { "title": "Intellectual Property & FTO", "status": "In Progress", "color": "amber" },
      { "title": "Final Report Status", "status": "Finalizing", "color": "amber" }
    ],
    "report_file": "/reports/pembrolizumab_NASH_repurposing_report.pdf"
  },
  "omeprazole_osteoporosis": {
    "title": "Report Compilation Progress",
    "description": "Synthesizing insights from all analyses to produce a comprehensive repurposing report for Omeprazole.",
    "sections": [
      { "title": "Executive Summary", "status": "Complete", "color": "green" },
      { "title": "Market & Competitive Analysis", "status": "Complete", "color": "blue" },
      { "title": "Clinical & Mechanistic Rationale", "status": "Complete", "color": "green" },
      { "title": "Intellectual Property & FTO", "status": "In Progress", "color": "amber" },
      { "title": "Final Report Status", "status": "Finalizing", "color": "amber" }
    ],
    "report_file": "/reports/omeprazole_osteoporosis_repurposing_report.pdf"
  },
  "rituximab_parkinson": {
    "title": "Report Compilation Progress",
    "description": "Synthesizing insights from all analyses to produce a comprehensive repurposing report for Rituximab.",
    "sections": [
      { "title": "Executive Summary", "status": "Complete", "color": "green" },
      { "title": "Market & Competitive Analysis", "status": "Complete", "color": "blue" },
      { "title": "Clinical & Mechanistic Rationale", "status": "Complete", "color": "green" },
      { "title": "Intellectual Property & FTO", "status": "In Progress", "color": "amber" },
      { "title": "Final Report Status", "status": "Finalizing", "color": "amber" }
    ],
    "report_file": "/reports/rituximab_parkinson_repurposing_report.pdf"
  },
  "ketamine_chronic_pain": {
    "title": "Report Compilation Progress",
    "description": "Synthesizing insights from all analyses to produce a comprehensive repurposing report for Ketamine.",
    "sections": [
      { "title": "Executive Summary", "status": "Complete", "color": "green" },
      { "title": "Market & Competitive Analysis", "status": "Complete", "color": "blue" },
      { "title": "Clinical & Mechanistic Rationale", "status": "Complete", "color": "green" },
      { "title": "Intellectual Property & FTO", "status": "In Progress", "color": "amber" },
      { "title": "Final Report Status", "status": "Finalizing", "color": "amber" }
    ],
    "report_file": "/reports/ketamine_chronic_pain_repurposing_report.pdf"
  },
  "pioglitazone_alzheimer": {
    "title": "Report Compilation Progress",
    "description": "Synthesizing insights from all analyses to produce a comprehensive repurposing report for Pioglitazone.",
    "sections": [
      { "title": "Executive Summary", "status": "Complete", "color": "green" },
      { "title": "Market & Competitive Analysis", "status": "Complete", "color": "blue" },
      { "title": "Clinical & Mechanistic Rationale", "status": "Complete", "color": "green" },
      { "title": "Intellectual Property & FTO", "status": "In Progress", "color": "amber" },
      { "title": "Final Report Status", "status": "Finalizing", "color": "amber" }
    ],
    "report_file": "/reports/pioglitazone_alzheimer_repurposing_report.pdf"
  },
  "ivermectin_oncology": {
    "title": "Report Compilation Progress",
    "description": "Synthesizing insights from all analyses to produce a comprehensive repurposing report for Ivermectin.",
    "sections": [
      { "title": "Executive Summary", "status": "Complete", "color": "green" },
      { "title": "Market & Competitive Analysis", "status": "Complete", "color": "blue" },
      { "title": "Clinical & Mechanistic Rationale", "status": "Complete", "color": "green" },
      { "title": "Intellectual Property & FTO", "status": "In Progress", "color": "amber" },
      { "title": "Final Report Status", "status": "Finalizing", "color": "amber" }
    ],
    "report_file": "/reports/ivermectin_oncology_repurposing_report.pdf"
  }
}
